[
  {
    "ts": "2025-10-03T21:50:02+00:00",
    "headline": "Abbott (ABT) Laps the Stock Market: Here's Why",
    "summary": "Abbott (ABT) reached $134.59 at the closing of the latest trading day, reflecting a +1.2% change compared to its last close.",
    "url": "https://finance.yahoo.com/news/abbott-abt-laps-stock-market-215002965.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "65ca81fc-722c-3946-9e7e-f8f2acc45afa",
      "content": {
        "id": "65ca81fc-722c-3946-9e7e-f8f2acc45afa",
        "contentType": "STORY",
        "title": "Abbott (ABT) Laps the Stock Market: Here's Why",
        "description": "",
        "summary": "Abbott (ABT) reached $134.59 at the closing of the latest trading day, reflecting a +1.2% change compared to its last close.",
        "pubDate": "2025-10-03T21:50:02Z",
        "displayTime": "2025-10-03T21:50:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2",
          "originalWidth": 900,
          "originalHeight": 469,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FhE.FTVPiyZE7qpXxRqaxQ--~B/aD00Njk7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2.cf.webp",
              "width": 900,
              "height": 469,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFRv_ZJmMJVPU2zxJKrzAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-abt-laps-stock-market-215002965.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-abt-laps-stock-market-215002965.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-03T21:24:00+00:00",
    "headline": "Top Stock Reports for AMD, Abbott & Micron Technology",
    "summary": "AMD, Abbott and Micron shine in fresh Zacks reports, highlighting AI momentum, product pipelines and strong financial positioning.",
    "url": "https://finance.yahoo.com/news/top-stock-reports-amd-abbott-212400405.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8d742f9f-50fb-33db-b145-299595d68fa7",
      "content": {
        "id": "8d742f9f-50fb-33db-b145-299595d68fa7",
        "contentType": "STORY",
        "title": "Top Stock Reports for AMD, Abbott & Micron Technology",
        "description": "",
        "summary": "AMD, Abbott and Micron shine in fresh Zacks reports, highlighting AI momentum, product pipelines and strong financial positioning.",
        "pubDate": "2025-10-03T21:24:00Z",
        "displayTime": "2025-10-03T21:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/c0a0d5596f2ebb626a8c1aabf1b4fb40",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0F0526VOc9dMr.vUWhCeXA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c0a0d5596f2ebb626a8c1aabf1b4fb40.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5z1.gCCdofTWeLJFJlUKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c0a0d5596f2ebb626a8c1aabf1b4fb40.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-stock-reports-amd-abbott-212400405.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-stock-reports-amd-abbott-212400405.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COP"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-03T13:30:02+00:00",
    "headline": "Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?",
    "summary": "The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
    "url": "https://finance.yahoo.com/news/abbott-abt-considered-good-investment-133002193.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "43f380c9-947e-395a-ab44-390ed8878ce4",
      "content": {
        "id": "43f380c9-947e-395a-ab44-390ed8878ce4",
        "contentType": "STORY",
        "title": "Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?",
        "description": "",
        "summary": "The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
        "pubDate": "2025-10-03T13:30:02Z",
        "displayTime": "2025-10-03T13:30:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/17a4db66bb13bdabcbf848550a6ea15a",
          "originalWidth": 900,
          "originalHeight": 587,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ek3sCkIesNduKxaAvxa7kg--~B/aD01ODc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/17a4db66bb13bdabcbf848550a6ea15a.cf.webp",
              "width": 900,
              "height": 587,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jPitQItFTnNGhYOMdmCObQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/17a4db66bb13bdabcbf848550a6ea15a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-abt-considered-good-investment-133002193.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-abt-considered-good-investment-133002193.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-03T12:32:53+00:00",
    "headline": "Should Health Canadaâ€™s Approval of Abbott (ABT) Dissolvable Stent Drive a Rethink for Investors?",
    "summary": "Abbott Laboratories recently received Health Canada approval for the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind dissolvable stent designed to treat chronic limb threatening ischemia below the knee using a minimally invasive approach. This innovative device not only keeps arteries open and supports vessel healing, but also significantly reduces the need for repeat procedures in a condition with high rates of amputation and mortality. We'll explore how...",
    "url": "https://finance.yahoo.com/news/health-canada-approval-abbott-abt-123253107.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "c9c5d029-d195-38e3-b137-3ac6d9edd33c",
      "content": {
        "id": "c9c5d029-d195-38e3-b137-3ac6d9edd33c",
        "contentType": "STORY",
        "title": "Should Health Canadaâ€™s Approval of Abbott (ABT) Dissolvable Stent Drive a Rethink for Investors?",
        "description": "",
        "summary": "Abbott Laboratories recently received Health Canada approval for the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind dissolvable stent designed to treat chronic limb threatening ischemia below the knee using a minimally invasive approach. This innovative device not only keeps arteries open and supports vessel healing, but also significantly reduces the need for repeat procedures in a condition with high rates of amputation and mortality. We'll explore how...",
        "pubDate": "2025-10-03T12:32:53Z",
        "displayTime": "2025-10-03T12:32:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7zJOBZ6wPnYKbKPRmWh.qQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc9EgsXKjWnUzlOQpxWhqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/health-canada-approval-abbott-abt-123253107.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/health-canada-approval-abbott-abt-123253107.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-03T09:54:00+00:00",
    "headline": "Medtronic wins CE mark for Penditure LAA exclusion device",
    "summary": "The company plans to launch the device in Europe late next week, providing competition for AtriCureâ€™s AtriClip product.",
    "url": "https://www.medtechdive.com/news/medtronic-ce-mark-penditure-laa-exclusion/801888/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "98f6457a-7704-3ac6-a3e6-faf7aeef97f3",
      "content": {
        "id": "98f6457a-7704-3ac6-a3e6-faf7aeef97f3",
        "contentType": "STORY",
        "title": "Medtronic wins CE mark for Penditure LAA exclusion device",
        "description": "",
        "summary": "The company plans to launch the device in Europe late next week, providing competition for AtriCureâ€™s AtriClip product.",
        "pubDate": "2025-10-03T09:54:00Z",
        "displayTime": "2025-10-03T09:54:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/b209ae8493f9dbfe56aaf87339115dfb",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Medtronic's operational headquarters are in Minneapolis, Minnesota.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pSBQ166DiuxRuaW4sXYf9Q--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/b209ae8493f9dbfe56aaf87339115dfb.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Czne7JksVB_WJ7zZwaPX3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/b209ae8493f9dbfe56aaf87339115dfb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/medtronic-ce-mark-penditure-laa-exclusion/801888/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/medtronic-wins-ce-mark-penditure-095400094.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "ATRC"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]